|Last Update: 05/20/13 - 4:01 PM EDT|
|YTD Performance: 19.71%|
|Previous Close: $64.13|
|52 Week Range: $49.59 - $65.10|
|Oustanding Shares: 138,189,927|
|Market Cap: 8,862,120,019|
|Qtr (06/13)||Qtr (09/13)||FY (12/13)||FY (12/14)|
|Number of Analysts||9||11||12||13|
|Growth Rate (Year over Year)||6.35%||14.88%||14.59%||10.36%|
Shares of CHD now seen reaching $67, Oppenheimer said. Fourth quarter momentum likely to continue into 2013. Outperform rating.
Shares of CHD now seen reaching $63, Oppenheimer said. Estimates also raised on Avid acquisition. Outperform rating.
Dan Fitzpatrick examines three stocks viewed on Fast Money. Today's stocks include Tibco Software, Arena Pharma, and Church & Dwight.
Shares of CHD now seen reaching $58, Oppenheimer said. Healthy organic sales growth. Outperform rating.
Shares of CHD now seen reaching $55, Oppenheimer said. Fourth quarter beat on organic growth, 2012 guidance looks achievable. Outperform rating.
CHD was downgraded from Outperform to Market Perform, BMO Capital said. $48 price target. Valuation call, as the stock was up 33% last year.
Utilities, consumer staples and healthcare have performed well in 2011 -- let's find some names worth keeping an eye on for 2012.
I like the consumer-products maker as a short setup for next week.
This mix of stocks and ETFs historically attract buyers in weak economic times.